MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Chorea as the initial presentation of Erdheim-Chester disease

I. Sarac, H. Sarac, S. Basic Kinda, F. Borovecki, N. Henigsberg, L. Lugovi Mihic (Zagreb, Croatia)

Meeting: 2025 International Congress

Keywords: Ataxia: Etiology and Pathogenesis, Chorea (also see specific diagnoses, Huntingtons disease, etc): Clinical features

Category: Choreas (Non-Huntington's Disease)

Objective: to describe clinical and radiological findings, and disease progression in a patient with Erdheim-Chester disease (ECD) initially presenting with chorea.

Background: ECD is a rare myeloid neoplasm characterized by xanthogranulomatous infiltration of histiocytes (CD68+/CD1-) of any organ, dominantly bone, retroperitoneum and brain. Neurological complication usually include ataxia, brain masses and reduced cerebral volume. This patient’s initially presented with chorea, cognitive impairment and ataxia, and then dysarthria, dys phagia and flaccid paraplegia appeared.

Method: A 68-year-old Caucasian man had a 3-year history of chorea, imbalance, impulsivity and cognitive decline. On examination, two years late, there was a severe flaccid paraparesis, dysarthria, dysphagia and “Cogan lid”. He was started on haloperidol 2.5 mg/daily two years ago. Laboratory investigation showed hypoalbuminaemia, while CSF paraprotein and antibodies were not detected.

Results: Brain MRI showed T2/FLAIR hyperintensity of the pons, middle cerebellar peduncles and vermis, without DWI signal restriction, and mild diffuse cortical atrophy. CT scan revealed perirenal and peri-aortic infiltration. Bone scintigraphy showed foci of increased uptake in the distal metadiaphysis of femurs and tibias and the same changes were visible on CT of the upper legs. A bone biopsy confirmed the diagnosis of ECD. This pateint was negative for BRAFv600E mutation and Huntington disease. Despite reduction in brain lesion, there was minimal improvement after treatment with corticosteroids and immunoglobulins after four months.

Conclusion: Although cerebellar and pyramidal symptoms are the main neurological manifestations, chorea can be presenting symptom of ECD. Brain involvement may not fully correlate with deficit, which may be a consequence of an additional neurodegenerative process, which could explain the lack of response to therapy.

To cite this abstract in AMA style:

I. Sarac, H. Sarac, S. Basic Kinda, F. Borovecki, N. Henigsberg, L. Lugovi Mihic. Chorea as the initial presentation of Erdheim-Chester disease [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/chorea-as-the-initial-presentation-of-erdheim-chester-disease/. Accessed November 20, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/chorea-as-the-initial-presentation-of-erdheim-chester-disease/

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley